Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for CorMedix (CRMD) over the last 8 years, with Q3 2025 value amounting to $3.6 million.

  • CorMedix's Amortizatization of Intangibles rose 954992.23% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 254111.04%. This contributed to the annual value of $155844.0 for FY2024, which is 1560.53% up from last year.
  • CorMedix's Amortizatization of Intangibles amounted to $3.6 million in Q3 2025, which was up 954992.23% from $51948.0 recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Amortizatization of Intangibles peaked at $3.6 million during Q3 2025, and registered a low of $27878.0 during Q1 2021.
  • Over the past 5 years, CorMedix's median Amortizatization of Intangibles value was $32221.5 (recorded in 2022), while the average stood at $258242.0.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 721.14% in 2022, then surged by 954992.23% in 2025.
  • Over the past 5 years, CorMedix's Amortizatization of Intangibles (Quarter) stood at $29701.0 in 2021, then increased by 7.27% to $31861.0 in 2022, then grew by 2.26% to $32582.0 in 2023, then soared by 42.5% to $46428.0 in 2024, then soared by 7653.94% to $3.6 million in 2025.
  • Its Amortizatization of Intangibles stands at $3.6 million for Q3 2025, versus $51948.0 for Q2 2025 and $51948.0 for Q1 2025.